Pure Global AI
NCT06365372Recruiting

Circulating MrgD in Pulmonary Hypertension

Circulating MrgD Change in Patients With Pulmonary Hypertension
Qilu Hospital of Shandong UniversityClinicalTrials.govdiagnostic test
Verified
Study focus
Disease/Condition
Pulmonary Hypertension
Drug/Device/Intervention
Western blot
Study type
Observational
Intervention type
diagnostic test
Sponsor & location
Primary sponsor
Qilu Hospital of Shandong University
Location
Jinan, China
Timeline & enrollment
Phase
N/A
Start date
Apr 10, 2024
End date
Jun 01, 2024
Enrollment
90 participants
Primary outcome

Circulating MrgD level

Summary

The aim of the study is to observe the change of the circulating MrgD level in patients with
 pulmonary hypertension compared with subjects without pulmonary hypertension.

ICD-10 classifications
Primary pulmonary hypertensionOther secondary pulmonary hypertensionPulmonary heart disease and diseases of pulmonary circulationPulmonary heart disease, unspecifiedPulmonary valve disorders
Data source
Registry
ClinicalTrials.gov
Trial ID
NCT06365372
Type
Non-Device Trial
About this record

Access comprehensive clinical trial information for NCT06365372 through Pure Global AI's free database. This phase not specified trial is sponsored by Qilu Hospital of Shandong University and is currently Recruiting. The study focuses on Pulmonary Hypertension. Target enrollment is 90 participants.

This page provides complete trial specifications, intervention details, outcomes, and location information. Pure Global AI offers free access to ClinicalTrials.gov data, helping medical device and pharmaceutical companies navigate clinical research efficiently.